Cedars Sinai Marina del Rey Hospital Alert COVID-19 (coronavirus)



New Meta-analysis Shows 69% of Urological Cancer Surgeries Were Robotic-assisted

Daniel Marcus';

By Daniel Marcus

Posted on October 30th, 2019 in Marina Robotics

Open Heart Surgery in Multivessel DiseaseThe first meta-analysis that analyzed the overall trend of robotic surgery in the field of urologic oncology revealed that currently most urologic cancer surgeries in the United States are performed using robotic assistance.

Robotic surgery is associated with minimal blood loss and perioperative complications as well as short hospital stay compared to open surgery. But, it costs more and takes a longer time to perform than open surgery, as per the meta-analysis. In 2005, out of the 105,300 surgeries performed to treat prostate, kidney, and bladder cancer, about 29.6% of cases were done using robotic surgery. After a decade, the number of cases using robotic assistance increased and this amounts up to 69.2% of the total 88,198 surgeries performed in 2015.  To be specific, radical prostatectomy (RP), partial nephrectomy (PN), and radical cystectomy (RC) were performed using robotic assistance in 85.4%, 66.1%, and 32.8% of cases, respectively. This data reveals that the use of robotic surgery is on the rise by 4-, 110, and 11-fold for RP, PN, and RC procedures respectively when compared to the statistics of the year 2005.

Meta-analysis Compared Robotic and Open Surgery

The data extracted from 181 papers that comprised 63,141 unique surgical cases were included in the meta-analysis. This helped to compare robotic and open surgical methods with regard to aspects such as functional, oncologic, and survival outcomes, cost, and perioperative complications. The meta-analysis showed that when compared with open surgery, robotic surgery was associated with minimal post-surgical complications, less blood loss, and also required a shorter stay at the hospital. Robot-assisted RP resulted in improved continence and potency rates compared to open RP. Thus, the meta-analysis supports robotic surgery so that it can be considered a standard of care in most aspects of oncologic surgery, especially in radical prostatectomy.

Robotic Surgery Is Minimally Invasive, Ensures Quick Recovery

The patients can undergo very complex robotic surgeries without any long-term disability as these are minimally invasive and involve precise surgical dissections. Surgeons have better control in the removal of tissue, which reduces bleeding. Based on the meta-analysis, though the operating time is longer and the cost is higher compared to open surgery, robotic surgery has been able to win comprehensive acceptance in the health care system, particularly in urologic cancer surgical management.